This study is in progress, not accepting new patients
A Study of NGM621 in Participants With Geographic Atrophy
Summary
- Eligibility
- for people ages 55 years and up (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- NGM Biopharmaceuticals, Inc
- ID
- NCT04465955
- Phase
- Phase 2 research study
- Study Type
- Interventional
- Participants
- At least 320 people participating
- Last Updated